GI & Endoscopy

The FDA approved Synergy Pharmaceuticals' irritable bowel syndrome with constipation treatment Trulance.

The American Gastroenterological Association launched My IBD Manager, an application for patients with inflammatory bowel disease.

Here are 19 gastroenterologists that made headlines in December 2017.

Here are 10 updates on GI companies from the past week.

Gainesville, Va.-based Gastroenterology Associates partnered with Elligo Health Research to provide clinical research services to patients.

Owings Mills, Md.-based Chesapeake Urology partnered with HIFU Prostate Services to provide non-invasive HIFU treatments for prostate cancer.

Using patient-derived three-dimensional 'organoid' models may help personalize therapy for people with GI cancers, according to a BJS review.

David Scholz, MD, is a gastroenterologist at Charlotte (N.C.) Gastroenterology & Hepatology.

Fecal immunochemical testing is a noninvasive alternative to colonoscopy, but researchers at three U.S.-based universities are examining how effective the testing really is.

Pharmaceutical companies Pierre Fabre and Array BioPharma conducted a phase III trial evaluating a triple combination therapy for metastatic colorectal cancer patients, Labiotech reports.